Prevalence and clinical correlates of clinical red flags for rare diseases in consecutive patients presenting with HCM phenotype

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Niccolo' Maurizi

University Hospital of Lausanne, Lausanne (Switzerland)

4 More presentations in this session

Presentation thumbnail

Metoprolol improves left ventricular longitudinal function at rest and during exercise in obstructive hypertrophic cardiomyopathy

Mrs A. Dybro (Aarhus, DK)

Abstract Slides Video

Presentation thumbnail

Mavacamten induces a clinical, hemodynamic, and biomarker response beyond the primary endpoint in EXPLORER-HCM: results from a post hoc machine learning analysis

Doctor I. Olivotto (Florence, IT)

Abstract Slides Video

Presentation thumbnail

Temporal trends, characteristics and comorbidities of patients with hypertrophic cardiomyopathy in denmark from 2005-2018: A nationwide cohort study.

Doctor C. Zoerner (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort

Doctor M. Brandao (Madrid, ES)

Abstract Slides Video

Access the full session

Session thumbnail

Hypertrophic cardiomyopathy: not so rare, but not so easy

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Not every thick wall you see in Echo is an HCM, about 2 daily practice cases?

Congress Presentation

A particular form of hypertrophic cardiomyopathy associated with neurological and metabolic disorder – the MELAS syndrome

Congress Presentation

Severe left ventricular hypertrophy and extensive fibrosis with concomitant arterial hypertension: a diagnostic dilemma.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources